
Auteur A. LUF
|
Documents disponibles écrits par cet auteur (3)

P. E. OOMEN ; D. SCHORI ; K. TOGEL-LINS ; D. ACREMAN ; S. CHENORHOKIAN ; A. LUF ; A. KARDEN ; C. PAULOS ; E. FORNERO ; E. GERACE ; R. P. J. KONING ; L. GALINDO ; L. A. SMIT-RIGTER ; F. MEASHAM ; M. VENTURA | 2022
Dans International Journal of Drug Policy (Vol.100, February 2022) Article : PériodiqueBackground: European drug checking services exchange information on drug trends within the Trans European Drug Information (TEDI) network, allowing monitoring and coordination of responses. Starting in Spring 2020, several services detected the [...]
O. KUDLACEK ; T. HOFMAIER ; A. LUF ; F. P. MAYER ; T. STOCKNER ; C. NAGY ; M. HOLY ; M. FREISSMUTH ; R. SCHMID ; H. H. SITTE | 2017
Dans Journal of Chemical Neuroanatomy (Vol.83-84, October 2017) Article : PériodiqueCocaine is a naturally occurring and illicitly used psychostimulant drug. Cocaine acts at monoaminergic neurotransmitter transporters to block uptake of the monoamines, dopamine, serotonin and norepinephrine. The resulting increase of monoamines[...]
R. Q. VROLIJK ; F. MEASHAM ; A. QUESADA ; A. LUF ; D. SCHORI ; S. RADLEY ; D. ACREMAN ; J. SMITH ; M. VERDENIK ; D. MARTINS ; M. CUNHA ; C. J. PAULOS ; I. F. PICCININ ; E. GERACE ; A. KARDEN ; R. P. J. KONING ; L. A. SMIT-RIGTER ; M. VENTURA | 2022
Dans Drugs, Habits and Social Policy (Vol.23, n°3, 2022) Article : PériodiquePurpose: The 3,4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has increased enormously throughout Europe across the past decade. This study aims to determine whether this is caused by the production of "stronger" tablets (more [...]